These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24921183)

  • 1. [Connective tissue diseases in hospital practice in Ouagadougou (Burkina Faso)].
    Ouédraogo DD; Korsaga-Somé N; Zabsonné Tiendrébéogo J; Tiéno H; Kaboré H; Niamba P; Drabo J
    Med Sante Trop; 2014; 24(3):271-4. PubMed ID: 24921183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiological profile, clinical and therapeutic cutaneous leishmaniasis in the Department of Dermatology at University Hospital in Ouagadougou, Burkina Faso].
    Bamba S; Barro-Traoré F; Drabo MK; Gouba A; Traoré A; Guiguemdé TR
    Rev Med Brux; 2013; 34(5):392-6. PubMed ID: 24303652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Semiological features and risk factors associated with osteoarthritis of the hip in Ouagadougou (Burkina Faso)].
    Ouédraogo DD; Ouédraogo T; Tiéno H; Zabsonré-Tiendrébéogo J; Pédro C; Draho J
    Med Sante Trop; 2015; 25(1):102-4. PubMed ID: 25296266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological study of patients with connective tissue diseases in Brazil.
    Almeida Mdo S; Bértolo MB; Da Silva BB; De Deus Filho A; Almeida MM; Veras FF; Mendes LC
    Trop Doct; 2005 Oct; 35(4):206-9. PubMed ID: 16354468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rheumatologic diseases and haemoglobinopathies in Ouagadougou (Burkina Faso)].
    Ouédraogo DD; Nacoulma EW; Kafando E; Ouédraogo A; Tiéno H; Koulidiaty J; Drabo JY
    Bull Soc Pathol Exot; 2010 May; 103(2):80-3. PubMed ID: 20387032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of rheumatologic diseases in a department of rheumatology in Ouagadougou (Burkina Faso).
    Ouédraogo DD; Ntsiba H; Tiendrébéogo Zabsonré J; Tiéno H; Bokossa LI; Kaboré F; Drabo J
    Clin Rheumatol; 2014 Mar; 33(3):385-9. PubMed ID: 24716217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Connective tissue diseases in the hospital setting in Lomé: a retrospective study of 231 cases].
    Teclessou JN; Saka B; Akakpo SA; Matakloe H; Mouhari-Toure A; Kombate K; Oniankitan I; Pitche P
    Pan Afr Med J; 2018; 30():176. PubMed ID: 30455805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
    Bodolay E; Szegedi G
    Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress of Autoantibody Examinations for Connective Tissue Diseases].
    Akashi K; Saegusa J; Morinobu A
    Rinsho Byori; 2015 May; 63(5):562-9. PubMed ID: 26524895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease.
    Conti V; Leone MC; Casato M; Nicoli M; Granata G; Carlesimo M
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):54-7. PubMed ID: 25781195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
    Clegg DO; Williams HJ; Singer JZ; Steen VD; Schlegel S; Ziminski C; Alarcón GS; Luggen ME; Polisson RP; Willkens RF
    J Rheumatol; 1991 Sep; 18(9):1340-3. PubMed ID: 1757935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Connective tissue diseases in the hospital outpatient service in Lomé (Togo)].
    Mijiyawa M; Amanga K; Oniankitan OI; Pitché P; Tchangaï-Walla K
    Rev Med Interne; 1999 Jan; 20(1):13-7. PubMed ID: 10220815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of autoantibodies profile in systemic lupus erythematosus according to age and clinical manifestations].
    Diallo MS; Mbengue B; Seck A; Ndao AC; Niang MS; Cissoko Y; Thiam A; Diop G; Diallo RN; Diallo M; Ndongo S; Dièye TN; Cissé M; Kane A; Dièye A
    Ann Biol Clin (Paris); 2014; 72(3):351-8. PubMed ID: 24876146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
    Jönsson G; Sjöholm AG; Truedsson L; Bengtsson AA; Braconier JH; Sturfelt G
    Rheumatology (Oxford); 2007 Jul; 46(7):1133-9. PubMed ID: 17478473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of the Connective Tissue Screening Questionnaire in northeast Pennsylvania to identify comorbidities of connective tissue diseases in subjects with systemic lupus erythematosus.
    Farrell MS; Wallace SJ; Clarke SM; Tarafder MR; McLaughlin WA
    J Prim Care Community Health; 2014 Apr; 5(2):134-8. PubMed ID: 24327597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interstitial lung disease in patients with connective tissue diseases].
    Hirakata M; Nakamura K; Kaburaki J; Suwa A; Mimori T; Kanazawa M; Akizuki M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():268-76. PubMed ID: 8752518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemoglobin sickle cell disease: experience of the Yalgado Ouedraogo University Hospital of Ouagadougou, Burkina Faso].
    Ayéroué J; Kafando E; Kam L; Gué E; Vertongen F; Ferster A; Cotton F; Gulbis B
    Arch Pediatr; 2009 Apr; 16(4):316-21. PubMed ID: 19261452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.